E.EisenbergL.LevinE
WHO Regional Office for Europe
Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma
Sandra is an extremely professional and personable nurse
it is not available for prescription outside authorised clinical trials
The study dataset comprised more than 174,000 patients and found that patients using GLP-1RAs demonstrated a 15% reduced risk of major cardiovascular events and a 19% lower risk of end-stage kidney disease